Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Mar Tulinius

Professor/ chief physician

Mar Tulinius
Professor/ chief physician
mar.tulinius@gu.se
+46 31-343 4780

Postal Address: Rondvägen 10, 41685 Göteborg
Visiting Address: Drottning silvias su/östra , 41685 Göteborg


Department of Pediatrics at Institute of Clinical Sciences (More Information)
Drottning Silvias Barn O ungdomsjukh
416 85 Göteborg
Visiting Address: Drottning Silvias Barn O ungdomsjukh , 416 85 Göteborg

Latest publications

Safety and effectiveness of ataluren: comparison of results from the STRIDE Registry and CINRG DMD Natural History Study
E. Mercuri, F. Muntoni, A. N. Osorio, M. Tulinius, F. Buccella et al.
Journal of Comparative Effectiveness Research, Journal article 2020
Journal article

Ataluren use in patients with nonsense mutation Duchenne muscular dystrophy: patient demographics and characteristics from the STRIDE Registry
F. Muntoni, I. Desguerre, M. Guglieri, A. N. Osorio, J. Kirschner et al.
Journal of Comparative Effectiveness Research, Journal article 2019
Journal article

Quality of life of patients with spinal muscular atrophy: A systematic review
E. Landfeldt, J. Edström, T. Sejersen, Mar Tulinius, H. Lochmüller et al.
European Journal of Paediatric Neurology, Review article 2019
Review article

NFL is a marker of treatment response in children with SMA treated with nusinersen
Bob Olsson, L. Alberg, Nicholas C Cullen, Eva Michael, Lisa Wahlgren et al.
Journal of Neurology, Journal article 2019
Journal article

A multinational study on motor function in early-onset FSHD.
Jean K Mah, Jia Feng, Marni B Jacobs, Tina Duong, Kate Carroll et al.
Neurology, Journal article 2018
Journal article

Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
E. Mercuri, B. T. Darras, C. A. Chiriboga, J. W. Day, C. Campbell et al.
New England Journal of Medicine, Journal article 2018
Journal article

Showing 71 - 80 of 105

2009

A novel homozygous RRM2B missense mutation in association with severe mtDNA depletion.
Gittan Kollberg, Niklas Darin, Karin Benan, Ali-Reza Moslemi, Sigurd Lindal et al.
Neuromuscular disorders : NMD, Journal article 2009
Journal article

Molecular basis of infantile reversible cytochrome c oxidase deficiency myopathy.
Rita Horvath, John P Kemp, Helen A L Tuppen, Gavin Hudson, Anders Oldfors et al.
Brain : a journal of neurology, Journal article 2009
Journal article

2008

Syn- och ögonförändringar hos 59 barn och ungdomar med genetisk verifierad mitokondriell sjukdom
Antovan Seyedi Honarvar , S Andersson, Niklas Darin, Mar Tulinius, Ali-Reza Moslemi et al.
Svenska Läkarsällskapets Riksstämma, Göteborg, Sverige, 26-28 nov 2008. Poster, Poster 2008
Poster

Ophthalmologic findings in 60 children and young adults with genetically verified mitochondrial disease
Antovan Seyedi Honarvar , S Andersson, Niklas Darin, Mar Tulinius, Ali-Reza Moslemi et al.
The 7th European Meeting on Mitochondrial Pathology, Stockholm, 11-14 juni 2008. Poster, Poster 2008
Poster

Development of orofacial dysfuntions in young individuals with myotonic dystrophy - a retrospective study.
Lotta Sjögreen, Monica Engvall, Stavros Kiliaridis, Mar Tulinius, Anette Lohmander
Journal of Medical Speech-Language Pathology, Journal article 2008
Journal article

Bone markers and bone mineral density in Duchenne muscular dystrophy
Ann-Charlott Söderpalm, P. Magnusson, Anne-Christine Åhlander, Jón Karlsson, Anna-Karin Kroksmark et al.
Journal of Musculoskeletal and Neuronal Interactions, Journal article 2008
Journal article

2007

Electrophysiological findings in children and young adults with genetically verified mitochondrial disease
Marita Andersson Grönlund, Antovan Seyedi Honarvar , Niklas Darin, Mar Tulinius, Susann Andersson
The European Pediatric Ophthalmology Society (EPOS), Portoroz, Slovenien, 4-6 okt 2007. Föredrag., Conference contribution 2007
Conference contribution

Showing 71 - 80 of 105

Page Manager: Katarina Olinder Eriksson|Last update: 10/1/2013
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?